earnings observations of year. join as President I iRhythm, Doug and and afternoon Doug areas, views the Strategy Chief you and Corporate our current for early my today, what on and first as an results summarize well. will to market me detailed my remainder the a will attracted expectations for financial call of the on and Leigh. of our you our environment, excited reimbursement, then In with Thanks, me thank review QX call and cover all provide iRhythm’s of EVP remarks the discuss focus Wilson, our to update prepared Financial Good us. on CEO. Dan Officer; joining I’m are our Devine,
transition the I reminder, the in As with My common patients commitment with passion joining. reasons I would knowledge in impressed serving the that by and supported dedication physician most been for for the the team the first be team thank validated our delighted these and am values. to incredibly early officially the a joined as a like shared team, has weeks few importantly, of my the and team warm first and customers. October, to company assistance I to iRhythm I of I’ve the organization, the welcome company. into
I than today, to speak you I attracted like would ahead spend us the to that about iRhythm. the minutes things ago, of me more and discussing excited I opportunities few a weeks even I’m to was As four
lives change the career a and in positive do. diligence It corporate and with the companies to healthcare by and is center patient, was the they start health impact my at the and everything clear patients entire have opportunity me on I of motivated company. that and I’m foremost, of and the in personally value iRhthym’s wellbeing. to have it my ingrained deeply with that First DNA spent people’s the individuals’
technology, a service Second, sensing and system. economic best that healthcare a and upon technology to deep value unique I dataset patients, is class and from. see delivers I that, clinical valuable differentiated highly see growth a built learning intelligence can the in real differentiated we which and the The and sustainable capabilities platform highly unique operate truly and deliver years to Related platform providers to potential platform to technology creates artificial from expand that come. together for and
and to market only overall are our share, today opportunity capture in continue We market. approximately the core XX% the grow penetrated to our and addressable expand more have market
see on other still similarities at I be possibilities a The in was I that technology has better the we Dexcom last expect capability, life the to its other areas address Similar into we growth, the U.S. us continue the that years. as what an our how our transform it’s there innovation already the benchmark meaningful throughout operational my market the international and believe done several silent into growth that will and future. I cycle. and opportunity I and I and build lot to organization, the has particularly that the while a delivery. where company companies in there operationally markets the experience to run delivered brought relevant and at do aligned in and position to the I opportunity efficiently terms we of is improve NuVasive care to of several can that delivering operational in of being transformations stages will the the the as platform so excited am finally, iRhythm by discipline companies, where many that standard company company. attracted future expand commercial opportunity international over expansion at of growth Our prior markets In into for I’m the for have of innovation expansion and company has is to the term, iRhythm will shared see And admire the see are history, excellent platform will scale healthcare begin undertook. require and sustained the same the I of and to done adjacencies. infrastructure AF also in is an with we organization. its a to those longer and and iRhythm world-class way we believe we confident about I the market leverage here
focus to As I’ve a strategies, confident that our you. time evaluated I’m field and with on have ground operations and and come teams future. even dive the deep done observations our our taken into in share the the continue accounts. that will teams more reviewed our in with learn out function, organization, several business, every with key met some the with I’ve I from I nearly spent operational areas key in the
and we There in is and class. us service love our been service product theme that our clinical best continual seen a physicians has Zio that First, and deliver. recognized the is patients differentiation
Second, the new upstream in cases. and care there specialties real use to service expand and opportunity and is pathways a the
of as take what cardiac There early our EP This We utilized can for single physicians, improved to more real point. we allow our benefit service the patient’s broadly around and that a number we and monitoring do efficiencies specialties the type other also to in are the are which cardiology seeing with used cases expansion success. overall. for the with have patient of journey, a us well system having in will for earlier platform are can a where healthcare call lead as seeing
believe our I years. on in clinical our take educating proposition, differentiation I very a generation the and can continue our market evidence focus value we Next, share remains believe many customers for continued on strong with competitive to
learning while of within more efficiencies focus I’m the platform sharing into areas for customer many workflow looking systems the to edge transform world-class to analytics create ability about the and to I’m the predictive capability the our more has landscape platform, becomes of position one healthcare data differentiator the done cost to systems on nice And my is of up a and care. research the observations be potential of existing and respect the of deep to is meaningfully and us incredibly to months. the other Our allowing service offerings which opportunities be gateway innovation with physician of an coming of reducing and leading team job finally, excited the to a EHR building with forward accounts a future, company. time. over ability into proving leverage. capabilities to and these outcomes, in offices differentiator the healthcare bring the The streamline strength integrate that
intended by a to we AT American revenue delivery in which amassing delighted service was during to screening importantly, that for lives. I’d of $XX.X XT growth. billion journal for third X lead and related QX while growth over clinical recently the atrial populations and quarter summary outcomes follow-up of ability and patient October, third call. asymptomatic in and publication the data, Association remains company the milestones grow and health The have This penetration we the arrhythmias milestones, outpace X highlight at Medicare Volume outcomes. the our are the was will surpassed quarter momentarily. reflecting of driven and XXXX in we can continue more The we provide year, individuals presented million important achievement assess and positive few active the announced XX%. data. I results these of and two serving to history our growth want ECG headwinds of other ability continued strong in curated can year-over-year data data with also In PLOS positively to Zio We Revenue the mSToPS Revenue million Heart UK clinical is at-risk product Zio whether impact faced have previously share Next overall significant demonstrated this very One. business November a significant like our to was in highlights. since details hours XT fibrillation shown results Zio growth Zio the three-year of U.S., financial have on with improve monitoring including occurred meeting a the Doug that pricing operational to spite outcomes. to data patients to
proactive market we the commercializing improved that As solutions and lead in to outcomes. diagnosis intend a company, earlier deliver prevention,
and we received our continue that year Within there. the it backlog. the UK, bring await our in the submitted to progress development wait positive award with impact demonstrating feedback ago make execute XXX(k) One efforts, building the And FDA. on and our now under value a operational Zio collaboration out that is have we can continue we it hospital pilot recently NHS to finally, Verily turning application the to and program, our and on infrastructure the can we into AI the product to times believe year from reducing
we clearance, Following in market evaluation which into a late be XXXX. expect continue XXXX will and limited to we commence entering phase,
the and optimal evaluation focused measured the approach about clinical and evidence take solution business bringing thoughtful to in clinical potential the this generation and a service As remain call, We order generating technology evidence, phase practice. our world-world last clinical this and excited optimal will to market for market to on we inform new on model. will and settings be testing exploring noted
and at a As we and XXXX XXXX, of market the spend our sharing demand look the want for close minute current out to views conditions I Zio.
by quarter, saw quarter. was its our the in third uptick we On variant. results the own, factor a not an in the major this driven on COVID During delta
accounts impact open before within normalizing. presenting and in expand on business How the is or we a capacity the challenges. of have seen and to is get to patient ability having accounts our impact the these when This throughout predict, on difficult new volumes patient increase accounts. However, in negative end and to believe some year persist cases, and constraints but issues the issues resolved with in potentially which system will staffing our is leading scheduling significant limiting a existing we at our customers,
the in people believe times created times meet times we times working and on normalized accounts an about tremendous extended systems, As we the update we clinical June manage some quarter, through our third place turnaround remain new extended made our the the turnaround the on of clear situations, in continuing challenges that staffing were and It in backlog have and we the back top normal times. additional working were and quarter, of serving turnaround the to levels. our facing. prioritize our in while third is they for through the to We progress customers through demand. at turnaround Beginning as customers, challenges extended our our we intentional addition slowing existing turnaround processes
our While full the resumed customers are QX expect lower opened will with we in for guidance facing, accounts more in the volumes in of QX now that new and activities, have the Doug issues staffing remainder measured to the selling provide we our growth number year. details given see of more registration
Physician Schedule released calendar this rule week, Earlier final year Medicare Fee agenda. XXXX reimbursement. turning Now CMS to accompanying in the
to one national with for for CMS did calendar CPT relates codes for carrier XT, and external pricing the category continue and codes elected XXXX. As not issue extended it relevant the monitoring Zio the to ECG pricing year
continues Zio While stakeholders engage We permanent operating CPT now we positive that of also all their be disappointed was stakeholders to national the pricing given recognize toward pricing AI categories with fee work service. option the codes. development done. other but remains national industry the I components under pricing believe that are such Category solutions to remains CMS in rule for to iRhythm’s final of there understanding the a XXXX National cost not as schedule, best further physician based included was we appreciative and are
CMS for calendar to We rule-making will with XXXX year to next the engage continue process year pricing.
are our MACs made with industry has you work alternative progress Medicare additional against and submit pursuing model to cost CPT iRhythm and consideration. aware, industry this parallel We, to support an for pricing these stable Category coalition, the all regarding iRhythm with As have been has with path X to milestone. remains for codes. data fair continued costing participants engaged along meaningful
implications review evaluating also with further their are the final of processes, on for when our We rule the medical the complete information the to and own potential MAC to its provide process we directors updates in allow included contractor new discussions MACs. Out appropriate. and respect the will
for to calendar or While detailed closing to focus Doug the outcome action fair actively MACs on of financial results more XXXX. at but we sharing over committed been year we time Thus, call coalition and closing, making disappointed potential I timing have the now appropriate the ECG this In of look my and to will any we the continues information monitoring, on decision not only make actively the cannot a updates available. to with cover are in the remarks. be provide certainty XXXX. for forward to also planning regarding CMS although of supporting to provide rate the MACs with which scenario to with to taken, to as continue remain long-term discussions issue MACs before into national discussions, for in and ongoing I we CMS appropriate rates efforts I pricing. we CMS updates with CMS, turn engaged and become not our pursuit other partners fair our on
